Sign in
4

Changes in Ownership

Dare Bioscience, Inc. Filed Acc 0001209191-17-002978

Options or other derivatives

  • Chief Executive Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GUIFFRE CHRISTOPHERD T · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-01-06 Grant or award : show line 1 in the form Stock Option (right to buy) +150,000 150,000 D
2017-01-06 Grant or award : show line 2 in the form Stock Option (right to buy) +150,000 150,000 D
Loading xslF345X03/doc4.xml…